🇺🇸 FDA

Drug profile · INN

voxelotor

OXBRYTA

approved B06AX03
US status
approved
Patents linked
0
News articles
0

Quick answer

voxelotor (OXBRYTA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN voxelotor
Brand OXBRYTA
Route ORAL
Formulation TABLET, FOR SUSPENSION
ATC code B06AX03

Frequently asked questions

What is voxelotor?

voxelotor (OXBRYTA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for voxelotor?

OXBRYTA is a marketed brand name for voxelotor. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of voxelotor?

voxelotor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.